Rauscher To Leave ACS when It Moves To Atlanta; Gadberry To Retire In March; Other VPs Stay On
In Brief: OMB Misses Deadline On 1989 Budget, Blames Late Actin On ’88 Money Bill; Raney Heads AACE
LAK/IL-2 Extramural Trials Expanded to 20 More cancers
New Jersey Center Takes Slice of DOE Budget for Cancer
Maxine Singer Wins Top SES Award
Nearly 3,000 certified As Oncology Nurses
OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - In The Headlines: Private funding can’t replace federal funding—but it can help
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”